Hana Pharm Better Medicine, Better Life
We're tracking Hana Pharm's market expansion
How Hana Pharm's international expansion compares to its competitors
Hana PharmYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Hana PharmYou | 0 | 0 | โ | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Chong Kun Dang ranked first in consumer interest among major Korean pharmaceutical companies in July-August, followed by Daewoong Pharmaceutical and GC Green Cross.
Yuhan Corporation ranked first in consumer interest among pharmaceutical companies in March 2026 with 9,376 online postings, followed by Hanmi Pharm and Dong-A Pharmaceutical.
Hana Pharma's Hospital Division Director Lee Il-gi sold 1,021 shares on January 6, 2026, reducing his stake to 10,000 shares or 0.05%.
Unlock verified emails & direct dials
Free ยท No credit card needed
Quick answers about Hana Pharm's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams fullโmarket visibility.โ
ยฉ 2026 Pubrio. All rights reserved.
